About Us: Once upon a time there was a site called Marci-kids. It was developed by Dr. Marcella Bothwell (Marci), ENT Rady Children's Hospital in San Diego, CA and Dr. Jeffrey Phillips Pharm. D, Director of Research in the Department of Surgery for the University of Missouri. The Marci-Kids site and the Infant Acid Reflux Solutions lab gathered data on hundred’s of infants with acid reflux and were involved in successfully treating those infants and children with acid reflux. Jeffrey Phillips (Dr. P), the inventor of Zegerid (a proton pump inhibitor used to treat adults with acid reflux).
The PPI dosing information that we show were performed and proven to be the most effective by Dr. Bothwell and Dr. P at the University of Missouri.
Dr. P: "What we learned was that infants metabolize the PPI drugs very quickly (~3 times faster than adults) and most importantly that the very low doses of PPIs (like Prevacid) that were being used were way too low to see any benefit and in some cases made matters worse by creating what is commonly know to most moms with little refluxers as The acid battle."
We continue to explain those fundamental principles that have been supported by medical literature and medical publications written by the medical professionals involved in treating infant acid reflux since the early 1990's.
Dr. P and the Infant Acid Reflux Solutions team is today and always we will be dedicated to providing as much information possible to the care givers of infants with reflux and offering treatment options to the families and their doctors for infants suffering from acid reflux.